Babson Diagnostics, a science-first health care technology business, announced that a key component of its BetterWay Blood Testing ecosystem has received FDA 510(k) clearance. These regulatory approvals open the way for Babson to launch BetterWay...
The U.S Food and Drug Administration (FDA) approved two gene therapies for sickle cell disease, including the first treatment in the country based on the Nobel Prize-winning CRISPR gene editing technique. Casgevy, developed by partners Vertex...
Immunotherapy works on the principle that the ability of the body and the immune system to recognize and eliminate cancer cells. One of the most promising tools in this regard is immune response inhibitors.
Bayer Pharmaceuticals Division in India has launched its engaging "#ReadyToSlowDown" campaign in collaboration with the Indian Society of Nephrology to encourage Indians to adopt a kidney-conscious lifestyle. "#ReadyToSlowDown" campaign is an...
Innovent Biologics, Inc. (Innovent), a world-class biopharmaceutical company, today announced an expansion of its licensing agreement with Synaffix B.V., a Lonza company focused on commercializing its clinical-stage platform technology for the...
The World Health Organization (WHO) has issued its first-ever guidelines on managing chronic low back pain (LBP) in primary and community care settings, outlining which therapies to utilize and which to avoid during regular care. Low back pain is...
Salus Optima, a leading provider of AI-enabled digital health and wellness solutions, and Bayer's consumer health division have formed a strategic alliance to help people age well. The collaboration advances both firms' common goal of transforming...
Antengene Corporation Limited (Antengene) announced that the Macau Pharmaceutical Administration Bureau has approved a New Drug Application (NDA) for Xpovio (selinexor) in combination with dexamethasone (Xd) for the treatment of adult patients...
Neurocrine Biosciences, Inc. announced it received Breakthrough Therapy designation from the US Food and Drug Administration (FDA) for crinecerfont in congenital adrenal hyperplasia. "We are very pleased that the FDA granted Breakthrough Therapy...
First Light Diagnostics announced that the FDA has approved the SensiTox B. anthracis Toxin Test for sale in the United States. Because of the ease with which B. anthracis spreads and the severe mortality and morbidity associated with inhalation...
, CDSCO.jpg)
.jpg)